P-Selectin Inhibition and the Structure–Activity Relationship of Sea Cucumber-Derived Fucosylated Glycosaminoglycan Oligosaccharides
Marine Drugs · 14.05.2026 · 24 (5) · 177
DOI: 10.3390/md24050177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 14.05.2026. Verfasst von Sujuan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Army Medical Center, Army Medical University, Chongqing 400042, China. Hauptthemen laut MEDLINE: Sea Cucumbers, P-Selectin, Glycosaminoglycans, Oligosaccharides. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Innovative Talent Support Program of the Army Medical Center, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
The selectin family constitutes a well-known class of immune-regulatory molecules, among which P-selectin has emerged as a therapeutic target for inflammatory thrombotic diseases due to its capacity to mediate the adhesion between multiple immune cell subsets and endothelial cells. Currently, small-molecule or glycomimetic inhibitors targeting P-selectin have stalled in Phase III clinical trials, with a common limitation being their weak binding affinity to P-selectin. In this study, in vitro competitive binding assays were employed to evaluate the inhibitory effects of structurally distinct fucosylated glycosaminoglycan (FG) oligosaccharides, derived from sea cucumbers, on the interaction between P-selectin and its ligands. A potent inhibitor, the nonasaccharide Ta-9-2 (featuring a novel disaccharide side chain), was identified. Biolayer interferometry (BLI) analysis further confirmed its high binding affinity to P-selectin, with a KD of 83.92 nM. Structure–activity relationship (SAR) analysis reveals that the appropriate glycan chain length, the novel disaccharide side chain (Gal4S6S-α1,2-L-Fuc3S-α1,3), and the favorable sulfation pattern (Fuc2S4S) serve as the molecular basis for potent P-selectin inhibition. This study provides a robust theoretical foundation for the structural optimization of glycomimetic targeting P-selectin, while also offering a new opportunity for the development of high-efficacy drug candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Army Medical Center, Army Medical University, Chongqing 400042, China.
- Key Laboratory of Geriatric Cardiovascular and Cerebrovascular Disease Research, Ministry of Education of China, Chongqing 400042, China.
- State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
- School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan 430074, China.
ORCID-Profile: Lisha Lin
Förderung
- National Natural Science Foundation of China
- Postdoctoral Innovative Talent Support Program of the Army Medical Center
- Natural Science Foundation of Hubei Province
- Postdoctoral Innovative Talent Support Program of Army Medical Center, Army Medical University
Zitieren
APA
Li, S., Lin, L., Yang, L., Pan, Y., Gao, N., Yin, R., Zeng, C., & Zhao, J. (2026). P-Selectin Inhibition and the Structure–Activity Relationship of Sea Cucumber-Derived Fucosylated Glycosaminoglycan Oligosaccharides. Marine Drugs, 24(5), 177. https://doi.org/10.3390/md24050177
Vancouver
Li S, Lin L, Yang L, Pan Y, Gao N, Yin R, et al. P-Selectin Inhibition and the Structure–Activity Relationship of Sea Cucumber-Derived Fucosylated Glycosaminoglycan Oligosaccharides. Marine Drugs. 2026;24(5):177. doi:10.3390/md24050177
BibTeX
@article{Li2026,
author = {Li, Sujuan and Lin, Lisha and Yang, Lian and Pan, Ying and Gao, Na and Yin, Ronghua and Zeng, Chunyu and Zhao, Jinhua},
title = {P-Selectin Inhibition and the Structure–Activity Relationship of Sea Cucumber-Derived Fucosylated Glycosaminoglycan Oligosaccharides},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {5},
pages = {177},
doi = {10.3390/md24050177}
}
EUVIMED